Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-938-4 | CAS number: 28214-91-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
In a limit test 5 rats/sex received 2500 mg/kg bw of the test substance by gavage (PSL 1981 (1)). 3 females died with severe nasal bleedings before day 5. Macroscopic examination revealed pulmonary hemorrhage, intestinal hemorrhage, discolored kidney, necrosis of spleen and necrosis of liver in these animals. In addition bodyweight (gain) was decreased. Other animals apeared normal during the observation period. The LD50 is > 2500 mg/kg bw.
In a second imit test 5 rats/sex received 2500 mg/kg bw of the test substance by gavage (PSL 1981 (2)). 2 females died before day 3. Macroscopic examination revealed pulmonary hemorrhages In addition bodyweight (gain) was decreased. Other animals apeared normal during the observation period. The LD50 is > 2500 mg/kg bw.
Acute inhalation toxicity
Rats (5/sex) were exposed to the test substance at 5.2 mg/L by inhalation (no information on actual concentration generated) (PSL 1981). No mortality or clinical signs were observed. Body weight gain in females was decreased over the 14 -day observation period. It is therefore concluded that the LC50 is >5.2 mg/L.
Acute dermal toxicity
Five rabbits/sex were treated dermally with 1000 mg/kg bw of the test substance for 24 hours (PSL 1981). One female died on day 1. All other animals appeared healthy until the end of the 14 day observation period. Therefore it is concluded that the test substance is of minor toxicity with an LD50 > 1000 mg/kg bw.
Studies on acute oral and dermal toxicity are available on DNNSA and BaDNNSA. These studies are indicative of low toxicity via both routes of exposure and therefore show that both DNNSA and BaDNNSA are suitable candidates for read-across.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: limited report, non-GLP. The information in the report is limited to the information in the summary.
- Qualifier:
- according to guideline
- Guideline:
- other: FHSLA, CFR Title 21, para. 191.1.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic Farm
- Age at study initiation: not indicated
- Weight at study initiation: males: 252-281 g ; females: 224-264 g
- Fasting period before study: 18 hours
- Housing: individually
- Diet: Fisher Rat Chow ad libitum
- Water: ad libitum
- Acclimation period: 17 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- other: oil (not further specified)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50%
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 5 mL/kg bw
- No. of animals per sex per dose:
- 5 males + 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days (study seems to have been stopped after 7 days based on date of initiation and report date)
- Frequency of observations and weighing: not indicated; weighing at start and end of the study period
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- NA
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 500 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- 2 females died on day 2; 1 female on day 5
- Clinical signs:
- diarrhea 2 hours after dosing in all animals
nasal bleeding in females that died - Body weight:
- males: within normal ranges
females: decreased weight gain in females that died - Gross pathology:
- Females that died: Pulmonary Hemorrhage (all), Intestinal Hemorrhage (all), Discolored, kidney (2/3), necrosis of Spleen (2/3), necrosis of Liver (2/3)
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the outcome of this test, the LD50 is > 2500 mg/kg bw
- Executive summary:
In a limit test 5 rats/sex received 2500 mg/kg bw of the test substance by gavage. 3 females died with severe nasal bleedings before day 5. Macroscopic examination revealed pulmonary hemorrhage, intestinal hemorrhage, discolored kidney, necrosis of spleen and necrosis of liver in these animals. In addition bodyweight (gain) was decreased. Other animals appeared normal during the observation period. The LD50 is > 2500 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 500 mg/kg bw
- Quality of whole database:
- Information is sufficient to be used for classification and labelling
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- No study available with sufficient information on the tested concentration
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: limited report, non-GLP. The information in the report is limited to the information in the summary.
- Qualifier:
- according to guideline
- Guideline:
- other: FHSLA 16 CFR 1500
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Cedar Knoll
- Age at study initiation: not indicated
- Weight at study initiation: males; 2.34-2.96 kg; females; 2.30-2.73 kg
- Housing: individually
- Diet: Fisher Rabbit Pellets ad libitum
- Water: ad libitum
- Acclimation period: 37 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22 °C
- Humidity (%): not indicated
- Air changes (per hr): not indicated
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 4-5 cm2 ( in 3 males and 2 females abrasions were made on 5-6 cm2)
- Type of wrap if used: non-permeable patch secured with tape and elastic sleeve
REMOVAL OF TEST SUBSTANCE
- Washing (if done): none
TEST MATERIAL
- Amount(s) applied : 2mL
- Concentration (if solution): 50% - Duration of exposure:
- 24 hours
- Doses:
- 2 mL/kg
- No. of animals per sex per dose:
- 5 males + 5 females
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: not indicated; weight at start and end of the study
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- NA
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 mL/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- 1 female (skin abraded) died on day 1
- Clinical signs:
- none reported
- Body weight:
- weight loss in the female that died; other animals as expected
- Gross pathology:
- In the female that died: distension of stomach and gastrointestinal tract; disoloration of liver/kidney/heart
Other animals: no findings - Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of the test substance is > 1000 mg/kg bw.
- Executive summary:
Five rabbits/sex were treated dermally with 1000 mg/kg bw of the test substance for 24 hours. One female died on day 1. All other animals appeared healthy until the end of the 14 day observation period. Therefore it is concluded that the test substance is of minor toxicity with an LD50 > 1000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1 000 mg/kg bw
- Quality of whole database:
- Information is sufficient to be used for classification and labelling
Additional information
The available studies contain sufficient information to be used for risk assessment and classification and labelling. All tests are performed on a 50% formulation. The effect levels are based on active ingredient, as it is not expected that the diluent has contributed to the effects that were observed.
Justification for selection of acute toxicity – oral endpoint
Studies were conducted prior to GLP regulations but used methods generally consistent with accepted procedures. Two studies of eqial quality are available. Both can be indicated as key-study. The results of both studies are comparable. some mortality and effects were noted at 2500 mg/kg bw.
Justification for selection of acute toxicity – dermal endpoint
Study was conducted prior to GLP regulations but used methods generally consistent with accepted procedures. One animal died and no further adverse effects were observed.
Justification for classification or non-classification
Based on the outcome of the studies no classification for acute oral and acute inhalation toxicity is proposed.
For dermal toxicity, some mortality was observed at 1000 mg/kg bw, but in addition no toxicity was seen. The substance was tested in a formulation (exposure to 2000 mg/kg as formulation). The diluent material is not expected to have contributed to the effects. Therefore it is proposed not to classify the substance for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.